Skip to main content
. 2013 Jun 26;8(6):e67185. doi: 10.1371/journal.pone.0067185

Table 2. Most recent medically-attended infection diagnoses within 1 through 42 days prior to confirmed Guillain-Barré syndrome (GBS) onset, by recent influenza vaccinationa status, Vaccine Safety Datalink, 2009–2011.

Infection type ICD-9-CM Code Description Patients with infection and influenza vaccination 1 through 42 days prior to GBS onset (n = 3) Patients with infection but no influenza vaccination 1 through 42 days prior to GBS onset (n = 41)b
Upper or lowerrespiratory tract 382.9 Unspecified otitis media 5
460 Acute nasopharyngitis 1
461.9 Acute sinusitis unspecified 2
462 Acute pharyngitis 3
463 Acute tonsillitis 2
464.00 Acute laryngitis and tracheitis without obstruction 1
465.9 Acute upper respiratory infections of unspecified site 3 6
466.0 Acute bronchitis 4
482.42 Methicillin resistant pneumonia due to Staphylococcus aureus 1
486 Pneumonia, organism unspecified 7
487.1 Influenza with other respiratory manifestations 2
490 Bronchitis not specified as acute or chronic 7
510.9 Empyema without fistula 2
513.0 Abscess of lung 1
Gastrointestinal 008.45 Intestinal infection due to Clostridium difficile 1
008.8 Intestinal infection due to other organism not elsewhere classified 1
009.0 Infectious colitis enteritis and gastroenteritis 1
009.2c Infectious diarrhea 1
Unspecifiedviral infection 079.99 Unspecified viral infection 2
a

2009–10 monovalent inactivated influenza vaccine or 2010–11 trivalent inactivated influenza vaccine.

b

There may be >1 medically-attended infection diagnosis on the same day, resulting in more infection diagnoses than GBS patients.

c

The patient with a diagnosis of infectious diarrhea also tested positive for Campylobacter jejuni.